|
|||||
|
|
Comment on “Combining brentuximab vedotin with dexamethasone,high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.” |
|
| Authors: | Marco Picardi Claudia Giordano |
| Institution: | Department of Clinical Medicine and Surgery, Hematology Unit, Federico II University Medical School, Naples, Italy |
| Abstract: | |
| Keywords: | |